Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.

Nature | May 22, 2011

The differentiation of patient-derived induced pluripotent stem cells (iPSCs) to committed fates such as neurons, muscle and liver is a powerful approach for understanding key parameters of human development and disease. Whether undifferentiated iPSCs themselves can be used to probe disease mechanisms is uncertain. Dyskeratosis congenita is characterized by defective maintenance of blood, pulmonary tissue and epidermal tissues and is caused by mutations in genes controlling telomere homeostasis. Short telomeres, a hallmark of dyskeratosis congenita, impair tissue stem cell function in mouse models, indicating that a tissue stem cell defect may underlie the pathophysiology of dyskeratosis congenita. Here we show that even in the undifferentiated state, iPSCs from dyskeratosis congenita patients harbour the precise biochemical defects characteristic of each form of the disease and that the magnitude of the telomere maintenance defect in iPSCs correlates with clinical severity. In iPSCs from patients with heterozygous mutations in TERT, the telomerase reverse transcriptase, a 50% reduction in telomerase levels blunts the natural telomere elongation that accompanies reprogramming. In contrast, mutation of dyskerin (DKC1) in X-linked dyskeratosis congenita severely impairs telomerase activity by blocking telomerase assembly and disrupts telomere elongation during reprogramming. In iPSCs from a form of dyskeratosis congenita caused by mutations in TCAB1 (also known as WRAP53), telomerase catalytic activity is unperturbed, yet the ability of telomerase to lengthen telomeres is abrogated, because telomerase mislocalizes from Cajal bodies to nucleoli within the iPSCs. Extended culture of DKC1-mutant iPSCs leads to progressive telomere shortening and eventual loss of self-renewal, indicating that a similar process occurs in tissue stem cells in dyskeratosis congenita patients. These findings in iPSCs from dyskeratosis congenita patients reveal that undifferentiated iPSCs accurately recapitulate features of a human stem cell disease and may serve as a cell-culture-based system for the development of targeted therapeutics.

Pubmed ID: 21602826 RIS Download

Mesh terms: Cell Cycle Proteins | Cell Division | Cellular Reprogramming | Dyskeratosis Congenita | Fibroblasts | Gene Expression Regulation | Humans | Induced Pluripotent Stem Cells | Nuclear Proteins | RNA | Telomerase | Telomere

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: T32 CA009302
  • Agency: NHLBI NIH HHS, Id: U01 HL100397
  • Agency: NCI NIH HHS, Id: R01 CA125453-05
  • Agency: NHLBI NIH HHS, Id: RC1 HL100361-01
  • Agency: Intramural NIH HHS, Id: R01 CA111691
  • Agency: NCI NIH HHS, Id: R01 CA125453
  • Agency: Howard Hughes Medical Institute, Id: R01 AG033747-02
  • Agency: NCI NIH HHS, Id: R01 AG033747
  • Agency: NIA NIH HHS, Id: R01 CA111691-05
  • Agency: NIA NIH HHS, Id: RC1 HL100361
  • Agency: NCI NIH HHS, Id:
  • Agency: NHLBI NIH HHS, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.